Key result
Angiotensin II induced Egr-1, increased fibronectin and laminin mRNA levels, and decreased AT1-receptor mRNA levels in rat cardiac fibroblasts.
Why the study?
Does ANG II induce Egr-1 and matrix gene expression in cultured rat cardiac fibroblasts compared to other growth factors?
Does ANG II induce Egr-1 and matrix gene expression in cultured rat cardiac fibroblasts compared to other growth factors?
ANG II plays a prominent and direct role in cardiac fibroblast changes associated with cardiac hypertrophy by inducing protooncogene expression and enhancing fibronectin mRNA levels via the AT1 receptor.
Answers are grounded in this paper and cite their sources.
Ang II may promote fibroblast matrix remodeling; leaves open translation to human hypertrophy or therapy.
The purpose of the present investigation was to compare the effects of angiotensin II (ANG II) other growth factors implicated to play a role in ventricular hypertrophy on cardiac fibroblast changes associated with cardiac remodeling. These changes included induction of early growth response (Egr-1) gene and increases in message levels of extracellular matrix proteins. ANG II treatment (10(-10)-10(-6) M) of rat cardiac fibroblasts induced 1) Egr-1 and 2) a fourfold (P < 0.02) increase in fibronectin and a twofold (P = 0.05) increase in laminin mRNA levels but no increases in that of collagens I, III, or IV at 24-48 h, and 3) a decrease in AT1-receptor mRNA levels to 26% (P < 0.001) of basal at 4-6 h. These effects were all inhibited by the AT1-receptor blocker, losartan, but not AT2-receptor blockers. Immunostaining of cultured cells with antibody against rat fibronectin demonstrated positive staining of cells in serum-free medium; staining was more intense in cells treated with ANG II (10(-6) M, 48 h). Fluorescent-activated cell sorting using an antibody against rat AT1 receptor demonstrated a receptor signal in cells maintained in serum-free medium; however, the receptor signal was not detectable in ANG II-treated cells. Serum and epidermal growth factor (EGF) also induced Egr-1, but norepinephrine (NE) and endothelin (ET) had no effect. Serum increased fibronectin mRNA levels by twofold (P < 0.05). EGF, NE, and ET had no effect on matrix gene expression. Serum, EGF, and NE also transiently downregulated AT1-receptor mRNA levels at 4-6 h of treatment. These results demonstrate that 1) ANG II both induces protooncogene expression and enhances fibronectin mRNA levels in cultured cardiac fibroblasts, whereas EGF only induces Egr-1, and NE and ET have no effects on either function; 2) ANG II effects are primarily mediated by the AT1 receptor; and 3) growth factors can regulate AT1-receptor mRNA levels. Thus ANG II, relative to NE, ET, and EGF, appears to play a prominent and direct role in fibroblast changes associated with cardiac hypertrophy.
No takes yet. Share an insight, caveat, or question.
Iwami et al. (1996) studied Cardiac remodeling and ventricular hypertrophy. Angiotensin II (ANG II) vs. Basal/serum-free medium and other growth factors (EGF, NE, ET) was evaluated on Egr-1 and matrix gene expression (fibronectin, laminin) and AT1-receptor mRNA levels (p=<0.02). Angiotensin II induced Egr-1, increased fibronectin and laminin mRNA levels, and decreased AT1-receptor mRNA levels in rat cardiac fibroblasts.
Synapse has enriched 10 related papers. Consider them for comparative context: